Company news
Helix Biopharma Corp. (TSX:HBP) news
Helix Biopharma Corp. news releases on 6ix. Latest, Oct 27, 2023: Helix Biopharma Corp. Announces Fiscal 2023 Year-End Results
Press releases — page 2
Helix Biopharma Corp. Announces Fiscal 2023 Year-End Results
October 27, 2023
Helix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 10, 2023
Helix BioPharma Corp. Announces Closing of Private Placement of CAD $3 Million and Board Changes
August 22, 2023
Helix BioPharma Corp. Announces Fiscal 2023 Third Quarter Results
June 14, 2023
Helix Biopharma Corp. Announces Fiscal 2023 Second Quarter Results
March 15, 2023
Helix Biopharma Corp. Reports Voting Results
January 24, 2023
Helix Biopharma Corp. Announces Grant & Cancellation of Stock Options
January 9, 2023
Helix BioPharma Corp. Announces Fiscal 2023 First Quarter Results
December 14, 2022
Helix Biopharma Corp. Announces Board & Management Changes
December 8, 2022
Helix Biopharma Corp. Closes Private Placement of CAD $4.62 Million
November 3, 2022
HELIX BIOPHARMA CORP. Announces Fiscal 2022 Year-End Results
November 1, 2022
Helix BioPharma Corp. Appoints Dr. Frank Gary Renshaw as Chief Medical Officer
October 3, 2022
Helix Biopharma Corp. Appoints Gabrielle M Siegers as the Head of Research & Development
September 1, 2022
Helix Biopharma Corp. Announces Conclusion of Funding Agreement with Lind Global Macro Fund LP
August 30, 2022
Helix BioPharma Corp. Announces Scientific Collaboration with University Hospital Tuebingen
August 9, 2022
Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.
April 22, 2022
Helix Biopharma Corp. Closes Private Placement
April 21, 2022
Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members
April 18, 2022
Helix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement Subscription
April 13, 2022
Helix Announces Board Resignation
April 7, 2022
Helix Biopharma Corp. Announces Management and Board Changes
March 22, 2022
Helix Biopharma Corp. Announces Fiscal 2022 Second Quarter Results
March 16, 2022
Helix Biopharma Corp. Announces Unexpected Passing of Interim CEO and Chairman of the Board
March 16, 2022
CORRECTION: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period
March 11, 2022
Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period
March 11, 2022
Helix BioPharma Corp. Reports Voting Results and Appointment of New Board Director
January 28, 2022
Helix BioPharma Corp. Provides Corporate Update
December 31, 2021
Helix Biopharma Corp. Announces Fiscal 2022 First Quarter Results
December 15, 2021
Helix BioPharma Corp. Extends Period to Exercise Warrants
December 13, 2021
Helix Biopharma Corp. Announces Fiscal 2021 Year-End Results
December 9, 2021
Helix BioPharma Corp. Provides Third Bi-Weekly MCTO Status Update
November 30, 2021
Helix BioPharma Corp. Provides Second Bi-Weekly MCTO Status Update
November 15, 2021
Helix BioPharma Corp. Provides Bi-Weekly MCTO Status Update
November 1, 2021
Helix BioPharma Corp. Announces Delay of Annual Filings
October 15, 2021
Helix BioPharma Corp. Announces Appointment of Interim Chief Executive Officer
September 20, 2021
Helix BioPharma Corp. Announces Appointment of New Director
August 19, 2021
Helix BioPharma Corp. Announces Changes to the Company's Board of Directors and Management
June 30, 2021
Helix BioPharma Corp. Announces Appointment of New Auditor and Extends Period to Exercise Warrants
June 24, 2021
Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results
June 14, 2021
Helix BioPharma Corp. Announces Closing of First Tranche of Institutional Investment for Gross Proceeds of CAD$3.5 million
May 13, 2021
Helix BioPharma Corp. Announces Institutional Investment for Gross Proceeds of up to CAD$10 million
May 11, 2021
Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results
March 16, 2021
Helix BioPharma Corp. Appoints Dr. Frank Gary Renshaw To Scientific Advisory Board
February 16, 2021
Helix Biopharma Corp. Responds to Market Activity
January 13, 2021
Helix BioPharma Corp. Closes Private Placement
December 30, 2020
Helix BioPharma Corp. Finalizes Polish Subsidiary Divestiture
December 22, 2020
Helix Biopharma Corp. Announces Fiscal 2021 First Quarter Results
December 15, 2020
Helix BioPharma Corp. Signs Definitive Agreement to Fully Divest Polish Subsidiary
November 9, 2020
Helix BioPharma Corp. Announced Fiscal 2020 Year-End Results
October 29, 2020
Helix Biopharma Corp. Provides Polish Subsidiary Divestiture Update
September 30, 2020